BioSpace News Archive

The Board of Directors of CSL Limited announces that it has appointed Dr Paul McKenzie as Chief Executive Officer and Managing Director of CSL from 6 March 2023.

InMed Pharmaceuticals Inc., a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, announces the Company has entered into a service contract with Brio Financial Group to provide senior financial leadership and bookkeeping services.

NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, provided additional detail today on the poster presentation given on the Company’s first disclosed preclinical bispecific program, NGM936, at the American Society of Hematology (ASH) Annual Meeting.

AVITA Medical, Inc., a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, announced the results of its 2022 Annual Meeting of Stockholders, which was held virtually on December 12, 2022 .